Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| European Commission | OTHER |
| The European Regional and Local Health Authorities | OTHER |
| SIMG (Italian College of General Medicine) | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to evaluate whether telemonitoring of frail patients with chronic diseases produces benefits in terms of reduced readmissions, improved health related quality of life, and improved health status. In addition, the trial evaluates the economic and organisational impact of the telemonitoring service and examines its acceptability by patients and health professionals.
The study is designed to evaluate the impact of telemonitoring on the follow-up of elderly patients with one or more chronic diseases among heart failure, chronic obstructive pulmonary disease and diabetes. The particular target of patients selected has the particularity of being "frail" according to a set of social eligibility criteria, agreed by the clinicians participating at the study. General practitioners are the first clinicians in charge of managing these patients during the trial follow-up. The term of comparison is represented by a control group, followed by outpatient usual care.
From a clinical point of view, the trial will investigate how the remote monitoring of some clinical parameters contributes to reduce the access to healthcare facilities (emergency and planned hospitalization, bed-days, ER, specialist and GP visits), to improve the patients health-related quality of life and to reduce the anxiety about health conditions. A cost-effectiveness and cost-utility analysis will be carried out in order to determine if and how telemonitoring helps to limit the healthcare expenditure. The evaluation will deal also with organizational changes and task shift due to telemonitoring introduction and patients and professionals perception towards the service.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Control Group | No Intervention | Treatment as usual | |
| Telemonitoring for frail patients with chronic diseases | Experimental | Telemonitoring for frail patients with chronic diseases |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Telemonitoring for frail patients with chronic diseases | Procedure | Patients are equipped with a telemonitoring kit that can be composed by a portable wrist clinic device, a digital weight scale and a glucometer for clinical parameters measuring, according to the pathologies of the patient. The equipment is completed by a gateway device for data transmission. The patient can monitor a complete set of clinical parameters, such as pulse-oxymetry, heart rate, blood pressure, ECG, body weight and glycemia with a frequency set by the clinician in the personalized treatment plan. In the same protocol the clinician includes also the alarm thresholds that determine when the clinical measures are out-of-range. Data are transmitted to a regional eHealth centre where a group of operators keeps these information under control and alerts the general practitioner in case of worsening of symptoms. |
| Measure | Description | Time Frame |
|---|---|---|
| Number of emergency hospitalisations | 12 months |
| Measure | Description | Time Frame |
|---|---|---|
| Number of primary care visits. | 12 months | |
| Health related quality of life as measured by the SF 36 version 2 questionnaire | 12 months | |
| All cause mortality |
Not provided
Inclusion Criteria:
Age ≥ 65 years
Diagnosis of one or more of the following chronic diseases:
and at least one of the following Social inclusion criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Nicolò Seminara, MD | SIMG - LHA 9 of Treviso | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Local Heath Authority of Padova | Padova | Padova | Italy | |||
| Local Health Authority of Pieve di Soligo |
Not provided
| ID | Term |
|---|---|
| D029424 | Pulmonary Disease, Chronic Obstructive |
| D006333 | Heart Failure |
| ID | Term |
|---|---|
| D008173 | Lung Diseases, Obstructive |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |
| D002908 | Chronic Disease |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| 12 months |
| Number of visits to emergency department | 12 months |
| Number of elective hospital admissions | 12 months |
| Number of bed days for hospitalised patients | 12 months |
| Anxiety and depression status as measured by Hospital Anxiety and Depression Scale, HADS. | 12 months |
| Pieve di Soligo |
| Treviso |
| Italy |
| Local Health Authority of Treviso | Treviso | Treviso | Italy |
| Local Health Authority of Mirano | Mirano | Venezia | Italy |
| Local Heath Authority Veneziana | Venezia | Venezia | Italy |
| Local Heath Authority of Verona | Verona | Verona | Italy |
| Local Heath Authority of Thiene | Thiene | Vicenza | Italy |
| D020969 |
| Disease Attributes |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |